This company listing is no longer active
LogicBio Therapeutics Past Earnings Performance
Past criteria checks 0/6
Key information
-18.2%
Earnings growth rate
46.0%
EPS growth rate
Biotechs Industry Growth | -14.6% |
Revenue growth rate | 77.0% |
Return on equity | -168.7% |
Net Margin | -246.7% |
Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How LogicBio Therapeutics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 22 | 11 | -27 | 14 | -8 |
30 Jun 22 | 10 | -31 | 15 | 0 |
31 Mar 22 | 8 | -36 | 16 | -1 |
31 Dec 21 | 5 | -40 | 16 | 0 |
30 Sep 21 | 4 | -38 | 15 | 8 |
30 Jun 21 | 3 | -36 | 14 | 1 |
31 Mar 21 | 3 | -33 | 13 | -1 |
31 Dec 20 | 3 | -33 | 12 | 0 |
30 Sep 20 | 3 | -37 | 12 | 8 |
30 Jun 20 | 2 | -40 | 11 | 17 |
31 Mar 20 | 1 | -42 | 11 | 32 |
31 Dec 19 | 0 | -40 | 10 | 31 |
30 Sep 19 | 0 | -32 | 10 | 27 |
30 Jun 19 | 0 | -29 | 10 | 21 |
31 Mar 19 | 0 | -23 | 9 | 15 |
31 Dec 18 | 0 | -18 | 7 | 11 |
30 Sep 18 | 0 | -18 | 5 | 8 |
30 Jun 18 | 0 | -11 | 4 | 6 |
31 Mar 18 | 0 | -9 | 3 | 5 |
31 Dec 17 | 0 | -8 | 2 | 4 |
Quality Earnings: 0IF is currently unprofitable.
Growing Profit Margin: 0IF is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0IF is unprofitable, and losses have increased over the past 5 years at a rate of 18.2% per year.
Accelerating Growth: Unable to compare 0IF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0IF is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15%).
Return on Equity
High ROE: 0IF has a negative Return on Equity (-168.65%), as it is currently unprofitable.